Get started
Dare Bioscience, Inc.Dare Bioscience, Inc.Dare Bioscience, Inc.

Dare Bioscience, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

DARE chart


Full chart

DARE upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪27.84 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.43 USD
Net income (FY)
‪−30.16 M‬ USD
Revenue (FY)
‪2.81 M‬ USD
Shares float
‪8.56 M‬
Beta (1Y)
2.74

Employees


Employees (FY)
26
Change (1Y)
−4 −13.33%
Revenue / Employee (1Y)
‪108.00 K‬ USD
Net income / Employee (1Y)
‪−1.16 M‬ USD

About Dare Bioscience, Inc.


Sector
Health Technology
CEO
Sabrina Martucci Johnson
Headquarters
San Diego
Website
darebioscience.com
Founded
2015
FIGI
BBG001J2P362
Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DARE news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DARE is 3.20 USD — it has increased by 0.31% in the past 24 hours. Watch Dare Bioscience, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dare Bioscience, Inc. stocks are traded under the ticker DARE.
DARE stock has risen by 0.63% compared to the previous week, the month change is a −0.93% fall, over the last year Dare Bioscience, Inc. has showed a −11.41% decrease.
We've gathered analysts' opinions on Dare Bioscience, Inc. future price: according to them, DARE price has a max estimate of 39.00 USD and a min estimate of 12.00 USD. Watch DARE chart and read a more detailed Dare Bioscience, Inc. stock forecast: see what analysts think of Dare Bioscience, Inc. and suggest that you do with its stocks.
DARE reached its all-time high on Mar 19, 2015 with the price of 1,304.40 USD, and its all-time low was 2.67 USD and was reached on Dec 20, 2024. View more price dynamics on DARE chart.
See other stocks reaching their highest and lowest prices.
DARE stock is 1.57% volatile and has beta coefficient of 2.74. Track Dare Bioscience, Inc. stock price on the chart and check out the list of the most volatile stocks — is Dare Bioscience, Inc. there?
Yes, you can track Dare Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Dare Bioscience, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
DARE earnings for the last quarter are −0.55 USD per share, whereas the estimation was −0.69 USD resulting in a 19.71% surprise. The estimated earnings for the next quarter are −0.53 USD per share. See more details about Dare Bioscience, Inc. earnings.
Dare Bioscience, Inc. revenue for the last quarter amounts to ‪41.69 K‬ USD, despite the estimated figure of ‪1.03 M‬ USD. In the next quarter, revenue is expected to reach ‪1.33 M‬ USD.
DARE net income for the last quarter is ‪−4.70 M‬ USD, while the quarter before that showed ‪12.91 M‬ USD of net income which accounts for −136.42% change. Track more Dare Bioscience, Inc. financial stats to get the full picture.
No, DARE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 26.00 employees. See our rating of the largest employees — is Dare Bioscience, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dare Bioscience, Inc. EBITDA is ‪−23.08 M‬ USD, and current EBITDA margin is ‪−1.10 K‬%. See more stats in Dare Bioscience, Inc. financial statements.
Like other stocks, DARE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dare Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Dare Bioscience, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Dare Bioscience, Inc. stock shows the sell signal. See more of Dare Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.